Key findings from a joint survey conducted by Health Union and BBK Worldwide - featuring perspectives from pharmaceutical and biotechnology sponsors, physicians, and patients - challenge the long-held notion that physicians are reluctant to refer their patients to other specialists for access to clinical trials.